hVIVO plc
OPORF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $200 | $80 | $55 | $129 |
| - Cash | $44 | $37 | $28 | $16 |
| + Debt | $13 | $13 | $2 | $3 |
| Enterprise Value | $169 | $56 | $29 | $116 |
| Revenue | $63 | $56 | $51 | $37 |
| % Growth | 11.9% | 10.5% | 37.5% | – |
| Gross Profit | $63 | $13 | $9 | $36 |
| % Margin | 100% | 23.3% | 17.9% | 97.4% |
| EBITDA | $18 | $14 | $7 | $3 |
| % Margin | 28.4% | 25% | 14% | 8.3% |
| Net Income | $11 | $16 | -$1 | -$0 |
| % Margin | 17% | 28.8% | -1.5% | -0.2% |
| EPS Diluted | 0.016 | 0.024 | -0.001 | -0 |
| % Growth | -34% | 2,058.3% | -1,100% | – |
| Operating Cash Flow | $10 | $17 | $16 | -$2 |
| Capital Expenditures | -$2 | -$5 | -$1 | -$1 |
| Free Cash Flow | $8 | $12 | $15 | -$2 |